Intraperitoneal chemotherapy in ovarian carcinoma
Runhaar, E.A.; van Oosterom, A.T.; de Bruijn, E.A.; ten Bokkel Huinink, W.W.
Netherlands Journal of Medicine 30(1-2): 94-103
1987
ISSN/ISBN: 0300-2977 PMID: 3587464 Document Number: 299464
Document emailed within 1 workday
Related Documents
Ottevanger, P.B. 2009: Intraperitoneal chemotherapy in ovarian carcinoma. Life prolonging in selected patients Nederlands Tijdschrift Voor Geneeskunde 153(11): 503-507Menczer, J.; Ben-Baruch, G.; Rizel, S.; Brenner, H. 1995: Intraperitoneal chemotherapy with cisplatin and etoposide in ovarian carcinoma patients who are clinically in complete remission European Journal of Gynaecological Oncology 16(1): 12-17
Ryuko, K.; Iwanari, O.; Moriyama, M.; Moriyama, M.; Nakayama, S.; Miyako, J.; Kitao, M. 1991: Intraperitoneal chemotherapy through implantable injection port in patients with advanced ovarian (or tubal) carcinoma Gan to Kagaku Ryoho. Cancer and ChemoTherapy 18(11): 2052-2057
Sherman, A.I.; Rosenberg, R.; Fink, D. 1992: Use of intraperitoneal chemotherapy for treatment of ovarian cancer European Journal of Gynaecological Oncology 13(4): 295-305
Zylberberg, B.; Dormont, D.; Ravina, J.H.; Madelenat, P.; Salat-Baroux, J.; Ferrand, G.; Antoine, J.M.; Pennehouat, G. 1991: Ovarian carcinomas. Intraperitoneal chemotherapy by needle Presse Medicale 20(28): 1320-1326
De Gramont, A.; Marpeau, L.; Demuynck, B.; Louvet, C.; Varette, C.; Gonzalez-Canali, G.; Pigné, A.; Herbulot, P.; Lagadec, B.; Cady, J. 1991: Results of intraperitoneal chemotherapy of ovarian cancer Journal de Gynecologie Obstetrique et Biologie de la Reproduction 20(3): 387-392
Meng, F.H. 1994: Care of ovarian cancer treated with intraperitoneal chemotherapy Zhonghua Hu Li Za Zhi 29(1): 24-26
Miron, L.; Onofriescu, M.; Marinca, M. 2008: Controversies regarding intraperitoneal chemotherapy for advanced ovarian cancer Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 112(3): 583-589
Giseĭnov, K.D.; Beliaev, A.M.; Senchik, K.I.; Maksimov, S.I.; Urmancheeva, A.F.; Gafton, G.I.; Mikaia, N.A.; Beliaeva, O.A.; Kireeva, G.S.; Gorodnova, T.V.; Matveeva, N.S. 2014: Hyperthermic intraperitoneal chemotherapy in the treatment for recurrent ovarian cancer Voprosy Onkologii 60(3): 343-347
Wydra, D.; Emerich, J. 2002: Intraperitoneal hyperthermic perfusion chemotherapy in recurrent ovarian cancer Ginekologia Polska 73(11): 1044-1047
Sugiyama, T.; Kumagai, S.; Nishida, T.; Ushijima, K.; Matsuo, T.; Yakushiji, M.; Hyon, S.H.; Ikada, Y. 1998: Experimental and clinical evaluation of cisplatin-containing microspheres as intraperitoneal chemotherapy for ovarian cancer Anticancer Research 18(4b): 2837-2842
Samartzis, K.; Thomakos, N.; Liontos, M.; Kollia, D.; Malakasis, A.; Haidopoulos, D.; Bamias, A.; Rodolakis, A.; Loutradis, D. 2018: Is it the right moment to include hyperthermic intraperitoneal chemotherapy as standard in ovarian cancer management? a reappraisal Journal of Buon: Official Journal of the Balkan Union of Oncology 23(7): 19-23
Deng, C.; Huang, R.; Lian, L. 1996: Pharmacokinetic study of intraperitoneal chemotherapy with high-dose cisplatin for advanced ovarian cancer Zhonghua Fu Chan Ke Za Zhi 31(3): 159-162
Robella, M.; Vaira, M.; Marsanic, P.; Mellano, A.; Borsano, A.; Cinquegrana, A.; Sottile, A.; De Simone, M. 2014: Treatment of peritoneal carcinomatosis from ovarian cancer by surgical cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) Minerva Chirurgica 69(1): 27-35
Scarabelli, C.; Campagnutta, E.; Ciarmiello, G.; Sopracordevole, F.; Nenzi, F.; Perin, A.; Miotto, E. 1986: Cisplatin in high-volume intraperitoneal treatment of ovarian carcinoma Minerva Ginecologica 38(7-8): 609-612
Marsland, T.; Griffin, T.; Ansell, J.; Hunter, R. 1981: Control of intraperitoneal haemorrhage with antifibrinolytic therapy in a patient with ovarian carcinoma Thrombosis and Haemostasis 46(2): 566
Kocic, M.; Nikolic, S.; Zegarac, M.; Djurisic, I.; Soldatovic, I.; Milenkovic, P.; Kocic, J. 2016: Prognostic factors and outcomes of cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy in patients with advanced ovarian cancer - A single tertiary institution experience Journal of BUON: Official Journal of the Balkan Union of Oncology 21(5): 1176-1183
Nishikawa, A.; Hashimoto, H.; Takeda, M.; Kontani, K.; Miyatake, T.; Mimura, M.; Nagamatsu, M.; Yokoi, T. 2016: Retrospective analysis of the survival benefit of chemotherapy for recurrent or advanced epithelial ovarian carcinoma in patients previously treated with paclitaxel plus platinum-based chemotherapy European Journal of Gynaecological Oncology 37(4): 451-454
Ward, B.G.; Wallace, K. 1987: Localization of the monoclonal antibody HMFG2 after intravenous and intraperitoneal injection into nude mice bearing subcutaneous and intraperitoneal human ovarian cancer xenografts Cancer Research 47(17): 4714-4718
Akamo, Y.; Takeyama, H.; Mohri, N.; Teranishi, F.; Funahashi, H.; Manabe, T. 2000: An effective case of intraperitoneal and intra-arterial combined chemotherapy for unresectably advanced Borrmann type IV gastric carcinoma Gan to Kagaku Ryoho. Cancer and ChemoTherapy 27(12): 2005-2007